TickerFactsScreenerDevelopers

Black Diamond Therapeutics, Inc. (BDTX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2018: -$8.45M2019: -$24.67M2020: -$52.15M2021: -$100.15M2022: -$85.08M2023: -$66.72M2024: -$62.30M2025: $29.61M$29.61M
2018Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$29.61M+147.5%
2024-$62.30M+6.6%
2023-$66.72M+21.6%
2022-$85.08M+15.0%
2021-$100.15M-92.1%
2020-$52.15M-111.3%
2019-$24.67M-191.9%
2018-$8.45M—